All Stories

  1. Functional characterization of 84 PALB2 variants of uncertain significance
  2. Network of Interactions between ZIKA Virus Non-structural Proteins and Human Host Proteins
  3. Impact of amino acid substitutions at secondary structures in the BRCT domains of the tumor suppressor BRCA1: Implications for clinical annotation
  4. OUP accepted manuscript
  5. Modulation of the prostaglandin-endoperoxide synthase 2 gene expression by variant haplotypes: influence of the 3′-untranslated region
  6. The Role of PALB2 in the DNA Damage Response and Cancer Predisposition
  7. Reduced levels of resistance protein ABCB1 associated with worse prognosis in breast cancer patients
  8. DNA repair genes PAXIP1 and TP53BP1 expression is associated with breast cancer prognosis
  9. BRCA1 recruitment to damaged DNA sites is dependent on CDK9
  10. Synthetic Organotellurium Compounds Sensitize Drug-Resistant Candida albicans Clinical Isolates to Fluconazole
  11. Functional assays provide a robust tool for the clinical annotation of genetic variants of uncertain significance
  12. Enhancer scanning to locate regulatory regions in genomic loci
  13. Abstract 3025: Characterization of CDK9/BRCA1 complex in DNA damage response
  14. BRCA1 Circos: a visualisation resource for functional analysis of missense variants
  15. Galectin-3 Up-Regulation in Hypoxic and Nutrient Deprived Microenvironments Promotes Cell Survival
  16. Abstract 480: CDK9 (a novel BRCA1/BARD1 interaction partner) downregulates BRCA1-mediated transcription
  17. Probing Structure-Function Relationships in Missense Variants in the Carboxy-Terminal Region of BRCA1
  18. Characterization ofLGALS3(galectin-3) as a player in DNA damage response
  19. Epidermal growth factor receptor gene polymorphisms are associated with prognostic features of breast cancer
  20. Abstract 632: Characterization of BCCIP as a novel BARD1 interaction partner.
  21. Charting the Landscape of Tandem BRCT Domain-Mediated Protein Interactions
  22. A guide for functional analysis ofBRCA1variants of uncertain significance
  23. Abstract 2132: Characterization of galectin 3 as a novel BARD1 interaction partner
  24. Aminoglycoside-induced suppression of CYP2C19*3 premature stop codon
  25. Abstract 3927: Characterization of galectin 3 as a putative BRCA1/BARD1 ubiquitin E3 ligase substrate
  26. Abstract 1117: Characterization of BAT1 (UAP56) interaction with BARD1
  27. Ectopic expression of Histone H2AX mutants reveal a role for its post-translational modifications
  28. Analysis of a set of missense, frameshift, and in-frame deletion variants of BRCA1
  29. Pathogenicity of the BRCA1 missense variant M1775K is determined by the disruption of the BRCT phosphopeptide-binding pocket: a multi-modal approach
  30. Correction: Functional analysis of BRCA1 M1628V variant
  31. Determination of Cancer Risk Associated with Germ Line BRCA1 Missense Variants by Functional Analysis
  32. Functional assays for BRCA1 and BRCA2
  33. Functional Impact of Missense Variants in BRCA1 Predicted by Supervised Learning
  34. The P1812A and P25TBRCA1and the 5164del4BRCA2Mutations: Occurrence in High-Risk Non-Ashkenazi Jews
  35. Breast Cancer Susceptibility and the DNA Damage Response
  36. Functional impact of missense variants in BRCA1 predicted by supervised learning
  37. TGF β1 and PDGF AA override Collagen type I inhibition of proliferation in human liver connective tissue cells
  38. Gap junctions in hematopoietic stroma control proliferation and differentiation of blood cell precursors
  39. Stroma-mediated granulocyte-macrophage colony-stimulating factor (GM-CSF) control of myelopoiesis: spatial organisation of intercellular interactions
  40. The capacity of connective tissue stromas to sustain myelopoiesis depends both upon the growth factors and the local intercellular environment
  41. Acidic pH Modulates the Interaction between Human Granulocyte-Macrophage Colony-stimulating Factor and Glycosaminoglycans